Джозеф Меркола - Кето-навигатор

57. Zampelas A, Roche H, Knapper JM, et al. Differences in postprandial lipaemic response between Northern and Southern Europeans. Atherosclerosis. 1998 Jul; 139 (1): 83–93.

58. Perez-Jimenez F, Lopez-Miranda J, Mata P. Protective effect of dietary monounsaturated fat on arteriosclerosis: beyond cholesterol. Atherosclerosis. 2002 Aug; 163 (2): 385–398.

59. Dubnov G, Berry EM. Omega-6/omega-3 fatty acid ratio: the Israeli paradox. World Rev Nutr Diet . 2003; 92: 81–91.

60. Yam D, Eliraz A, Berry EM. Diet and disease – the Israeli paradox: possible dangers of a high omega-6 polyunsaturated fatty acid diet. Isr J Med Sci . 1996 Nov; 32 (11): 1134–1143.

61. Renaud S, de Lorgeril M, Delaye J, et al. Cretan Mediterranean diet for prevention of coronary heart disease. Am J Clin Nutr .1995 Jun 1; 61 (6): 1360s–1367s.

62. Covas MI, Nyyssonen K, Poulsen HE, et al. The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial. Ann Intern Med . 2006 Sep 5; 145 (5): 333–341.

63. Там же.

64. Is your olive oil fake? [Интернет]. Mercola.com. 2016 Dec 17 [открыто 4 июня 2018]. Доступно по адресу https://articles.mercola.com/sites/articles/archive/2016/12/17/fake-olive-oil.aspx.

1. Borkman M, Storlien LH, Pan DA, et al. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med . 1993 Jan 28; 328 (4): 238–244.

2. Vessby B, Gustafsson IB, Tengblad S, et al. Desaturation and elongation of Fatty acids and insulin action. Ann N Y Acad Sci .2002 Jun; 967: 183–195.

3. de Lorgeril M, Salen P, Defaye P, et al. Recent findings on the health effects of omega-3 fatty acids and statins, and their interactions: do statins inhibit omega-3? BMC Med . 2013; 11: 5.

4. Rise P, Ghezzi S, Priori I, et al. Differential modulation by simvastatin of the metabolic pathways in the n-9, n-6 and n-3 fatty acid series, in human monocytic and hepatocytic cell lines. Biochem Pharmacol . 2005 Apr 1; 69 (7): 1095–1100.

5. de Lorgeril M, Salen P, Guiraud A, et al. Lipid-lowering drugs and essential omega-6 and omega-3 fatty acids in patients with coronary heart disease. Nutr Metab Cardiovasc Dis . 2005 Feb; 15 (1): 36–41.

6. Nozue T, Yamamoto S, Tohyama S, et al. Comparison of effects of serum n-3 to n-6 polyunsaturated fatty acid ratios on coronary atherosclerosis in patients treated with pitavastatin or pravastatin undergoing percutaneous coronary intervention. Am J Cardiol .2013 Jun1; 111 (11): 1570–1575.

7. Harris JI, Hibbeln JR, Mackey RH, et al. Statin treatment alters serum n-3 and n-6 fatty acids in hypercholesterolemic patients. Prostaglandins Leukot Essent Fatty Acids . 2004 Oct; 71 (4): 263–269.

8. Kurisu S, Ishibashi K, Kato Y, et al. Effects of lipid-lowering therapy with strong statin on serum polyunsaturated fatty acid levels in patients with coronary artery disease. Heart Vessels. 2013 Jan; 28 (1): 34–38.

9. Nozue T, Yamamoto S, Tohyama S, et al. Effects of statins on serum n-3 to n-6 polyunsaturated fatty acid ratios in patients with coronary artery disease. Am J Cardiol . 2013 Jan 1; 111(1): 6–11.

10. Morris DH. Metabolism of alpha-linolenic acid. Flax Council of Canada . 2014.

11. Barcelo-Coblijn G, Murphy EJ. Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: benefits for human health and a role in maintaining tissue n-3 fatty acid levels. Prog Lipid Res . 2009 Nov; 48 (6): 355–374.

12. Al MD, Badart-Smook A, von Houwelingen AC, et al. Fat intake of women during normal pregnancy: relationship with maternal and neonatal essential fatty acid status. J Am Coll Nutr . 1996; 15 (1): 49–55.

13. Carlson SE, Werkman SH, Peeples JM, et al. Long-chain fatty acids and early visual and cognitive development of preterm infants. Eur J Clin Nutr . 1994 Aug; 48 Suppl 2: S27–30.

14. Hornstra G. Essential fatty acids in mothers and their neonates. Am J Clin Nutr . 2000 May; 71 (5 Suppl): 1262s–1269s.

15. Burdge GC, Wootton SA. Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr . 2002 Oct; 88: 411–420.

16. Docosahexaenoic acid (DHA). Monograph. Altern Med Rev . 2009; 14 (4): 391–399.

17. Hornstra G. Essential fatty acids in mothers and their neonates. Am J Clin Nutr . 2000 May; 71 (5 Suppl): 1262s–1269s.

18. Barcelo-Coblijn G, Murphy EJ. Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: benefits for human health and a role in maintaining tissue n-3 fatty acid levels. Prog Lipid Res . 2009 Nov; 48 (6): 355–374.

19. Там же.

20. Gibson RA, Neumann MA, Makrides M. Effect of increasing breast milk docosahexaenoic acid on plasma and erythrocyte phospholipid fatty acids and neural indices of exclusively breast fed infants. Eur J Clin Nutr . 1997 Sep; 51 (9): 578–584.

21. Hornstra G. Essential fatty acids in mothers and their neonates. Am J Clin Nutr . 2000 May; 71 (5 Suppl): 1262s–1269s.

22. Barcelo-Coblijn G, Murphy EJ. Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: benefits for human health and a role in maintaining tissue n-3 fatty acid levels. Prog Lipid Res . 2009 Nov; 48 (6): 355–374.

23. Youdim KA, Martin A, Joseph JA. Essential fatty acids and the brain: possible health implications. Int J Dev Neurosci . 2000 Jul-Aug; 18 (4–5): 383–399.

24. Willatts P, Forsyth JS, DiModugno MK, et al. Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age. Lancet. 1998 Aug 29; 352 (9129): 688–691.

25. Youdim KA, Martin A, Joseph JA. Essential fatty acids and the brain: possible health implications. Int J Dev Neurosci . 2000 Jul-Aug; 18 (4–5): 383–399.

26. Barcelo-Coblijn G, Murphy EJ. Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: benefits for human health and a role in maintaining tissue n-3 fatty acid levels. Prog Lipid Res . 2009 Nov; 48 (6): 355–374.

27. Lucas A, Morley R, Cole TJ, et al. Breast milk and subsequent intelligence quotient in children born preterm. Lancet. 1992 Feb 1; 339 (8788): 261–264.

28. Rodgers B. Feeding in infancy and later ability and attainment: a longitudinal study. Dev Med Child Neurol . 1978 Aug; 20 (4): 421–426.

29. Taylor B, Wadsworth J. Breast feeding and child development at five years. Dev Med Child Neurol . 1984 Feb; 26 (1): 73–80.

30. Rogan WJ, Gladen BC. Breast-feeding and cognitive development. Early Hum Dev . 1993 Jan; 31 (3): 181–193.

31. Horwood LJ, Fergusson DM. Breastfeeding and later cognitive and academic outcomes. Pediatrics. 1998 Jan; 101 (1): E9.

32. Lanting CI, Fidler V, Huisman M, et al. Neurological differences between 9-yearold children fed breast-milk or formula-milk as babies. Lancet. 1994 Nov 12; 344 (8933): 1319–1322.

33. Menkes JH. Early feeding history of children with learning disorders. Dev Med Child Neurol . 1977 Apr; 19 (2): 169–171.

34. Rodgers B. Feeding in infancy and later ability and attainment: a longitudinal study. Dev Med Child Neurol . 1978 Aug; 20 (4): 421–426.

35. Taylor B, Wadsworth J. Breast feeding and child development at five years. Dev Med Child Neurol . 1984 Feb; 26 (1): 73–80.

36. Hornstra G. Essential fatty acids in mothers and their neonates. Am J Clin Nutr . 2000 May; 71(5 Suppl): 1262s–1269s.